Juvena Therapeutics
Palo Alto, California, United States
How Juvena Therapeutics hit $4M revenue with a 39 person team in 2023.
Tissue regeneration is an essential and burgeoning field of medical science that focuses on restoring damaged or diseased tissues and organs in the human body. This area is of particular significance when it comes to elderly populations, due to the natural decline in regenerative capabilities and the increased prevalence of chronic diseases and tissue damage with age. The elderly often face longer recovery times and reduced healing capacities as a result of aging-related changes in their bodies. Factors such as a decline in stem cell function, decreased cellular proliferation, alterations in the extracellular matrix, and a less effective immune response contribute to these challenges. Therefore, the development of effective tissue regeneration strategies could vastly improve the quality of life and health outcomes for older adults. Tissue regeneration for the elderly encompasses several innovative approaches, including: 1. **Stem Cell Therapy:** Leveraging the body's own stem cells or those derived from donor sources to replace or rejuvenate damaged tissues. This can involve the direct injection of stem cells into the affected area or the use of stem cells to grow tissues in the lab that are then transplanted back into the patient. 2. **Biomaterials:** Developing and using materials that can support or guide the growth of new tissue. These biomaterials are designed to be biocompatible and can provide a scaffold for cells to adhere, multiply, and regenerate the damaged tissues. 3. **Gene Therapy:** Modifying or correcting defective genes that contribute to disease or impaired tissue regeneration. This approach can help in restoring normal cell function and enhancing the body's natural healing processes. 4. **Tissue Engineering:** Combining cells, engineering techniques, and suitable biochemical and physicochemical factors to improve or replace biological tissues. This can include the development of artificial organs or bioartificial tissues that are then implanted in the patient. 5. **Regenerative Medicine:** This broader category includes using the above methods alongside treatments that stimulate and guide the body's own repair mechanisms. It's a holistic approach aimed at restoring tissue function and involves understanding the mechanisms of aging and regeneration. For the elderly, these technologies and approaches need to be tailored to their unique physiological conditions and potential complications. Safety, ethical considerations, and the body's decreased resilience are paramount when designing regeneration treatments for older individuals. With advances in tissue regeneration techniques, there is the hopeful prospect of not only extending lifespan but also significantly improving the quality of life for the elderly, allowing them to maintain independence and health well into their later years.
2017
Founded
$4M
2023 Revenue
-----
YOY
$0
Funding
Juvena Therapeutics Revenue
In 2023, Juvena Therapeutics revenue run rate hit $4M in revenue.
-
2023
Juvena Therapeutics hit $4M in revenue in 2023
-
2017
Juvena Therapeutics launched in 2017 with $0 revenue
Juvena Therapeutics Funding History
No funding has been reported for Juvena Therapeutics yet.
Team
Juvena Therapeutics has 39 total employees.
| DISTRIBUTION | QTY |
|---|---|
| Total team size | 39 |
Founder / CEO
Hanadie Yousef
Q&A
-
What's your age?
-
-
Favorite online tool?
-
-
Favorite book?
-
-
Favorite CEO?
-
-
Advice for 20 year old self
-
Customers
Churn
Juvena Therapeutics Executives
| Name | Position | Working Email | Personal Email |
|---|---|---|---|
| Hanadie Yousef | CEO | - | - |
Juvena Therapeutics Employees
| Name | Position | Working Email | Personal Email |
|---|---|---|---|
| Hanadie Yousef | CEO | - | - |
Frequently Asked Questions about Juvena Therapeutics
-
When was Juvena Therapeutics founded?
Juvena Therapeutics was founded in 2017.
-
How much revenue does Juvena Therapeutics generate?
Juvena Therapeutics generates $4M in revenue.
-
Who is the CEO of Juvena Therapeutics
The CEO of Juvena Therapeutics is Hanadie Yousef.
-
How much funding does Juvena Therapeutics have?
Juvena Therapeutics raised $0.
-
How many employees does Juvena Therapeutics have?
Juvena Therapeutics has 39 employees.
-
Where is Juvena Therapeutics headquarters?
Juvena Therapeutics is headquartered at Palo Alto, California, United States
People Also Viewed
Textline
Textline is a business texting app that lets you text message customers from your computer. SMS is the most convenient communication channel for your team.
MaestroQA
Provider of an open market orchestration platform intended to track customer behavior and analyze their preferences. The company's platform tracks application usage, feedback, user psychology and analytics of customer experience to deliver personalized and coordinated marketing experiences across marketing channels, enabling managers to empower agents with real-time feedback, granular insight into agent performance and pinpointed coaching.
Clavister
Clavister is a provider of web based security and unified threat management software. The company offers virtual series network security products for virtual and cloud based security that include virtual private server, virtual private cloud and hosted data center. The company continues to grow by making periodic small acquisitions.
Timma
Provider of an online platform designed to help users to book for hair and massage services. The company's platform offers calendar and cash management services, enabling users to compare places easily by price, rating and location.
eifas
SaaS Financial Advisory Platform
Sensika Technologies
Sensika Technologies, a cloud-based, single-access-point information intelligence platform, supports sound and agile business decisions.